CAMBRIDGE, Mass., Sept. 3 (HSMN NewsFeed) -- Satori Pharmaceuticals Incorporated, a privately held developer of therapeutics for Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders, today announced that Steven Holtzman, CEO an... Biopharmaceuticals, Neurology, PersonnelSatori Pharmaceuticals (Source: HSMN NewsFeed)
Read the original Alzheimer's Group Resources article at MedWorm: Alzheimer's ...
Filed under - Alzheimer, alzheimers, news
No Comments so far.
Tags: alzheimers, alzheimers caregivers, alzheimers medication, alzheimers news



